Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H26N4O2.2C2H6O4S |
Molecular Weight | 606.709 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCS(O)(=O)=O.OCCS(O)(=O)=O.NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
InChI
InChIKey=NBVZMBLJRHUOJR-UHFFFAOYSA-N
InChI=1S/C20H26N4O2.2C2H6O4S/c21-19(22)15-5-9-17(10-6-15)25-13-3-1-2-4-14-26-18-11-7-16(8-12-18)20(23)24;2*3-1-2-7(4,5)6/h5-12H,1-4,13-14H2,(H3,21,22)(H3,23,24);2*3H,1-2H2,(H,4,5,6)
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. | 1990 Apr |
|
Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. | 2001 Apr 26 |
|
Final report on the safety assessment of Hexamidine and Hexamidine Diisethionate. | 2007 |
|
Visual outcome and rehabilitation in a case of bilateral acanthamoeba sclerokeratitis. | 2007 Oct |
|
In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. | 2007 Sep |
|
A new Sephadex-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model. | 2009 Aug |
|
p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation. | 2009 Aug 1 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6000
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
C018961
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
DTXSID60984372
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
023XA5Z50L
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
211-533-5
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
659-40-5
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
115848
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
023XA5Z50L
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
SUB12021MIG
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
3080571
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
100000080187
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY | |||
|
1939371
Created by
admin on Fri Dec 15 17:49:15 GMT 2023 , Edited by admin on Fri Dec 15 17:49:15 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD